Is USCMF or MRK a better dividend investment in 2026?

USCMF currently yields 1230.01% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: USCMF offers higher current income.

What is the dividend yield difference between USCMF and MRK?

USCMF has a forward dividend yield of 1230.01% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 1226.76 percentage points.

Home › Compare › USCMF vs MRK

USCMF vs MRK: Dividend Comparison 2026

USCMF yields 1230.01% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 USCMF wins by $117168278.89M in total portfolio value

INVESTMENT

TIME HORIZON10 years

USCMF

● Live price

1230.01%

Share price

$0.16

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$117168278.92M

Annual income

$101,013,284,413,450.45

Full USCMF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — USCMF vs MRK

📍 USCMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	USCMF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, USCMF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

USCMF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

USCMF

Annual income on $10K today (after 15% tax)

$104,551.05/yr

After 10yr DRIP, annual income (after tax)

$85,861,291,751,432.89/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, USCMF beats the other by $85,861,291,750,625.14/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of USCMF + MRK for your $10,000?

USCMF: 50%MRK: 50%

100% MRK50/50100% USCMF

Portfolio after 10yr

$58584139.48M

Annual income

$50,506,642,207,200.38/yr

Blended yield

86.21%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

USCMF

No analyst data

Altman Z

-135.1

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

USCMF buys

MRK buys

No recent congressional trades found for USCMF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricUSCMFMRK

Forward yield	1230.01% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$117168278.92M ✓	$30.7K
Annual income after 10y	$101,013,284,413,450.45 ✓	$950.29
Total dividends collected	$115966496.30M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: USCMF vs MRK ($10,000, DRIP)

Year	USCMF Portfolio	USCMF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$133,701	$123,001.23	$11,192	$351.54	+$122.5K → USCMF
2	$1,680,015	$1,536,954.74	$12,524	$392.70	+$1.67M → USCMF
3	$19,846,696	$18,049,080.15	$14,015	$438.65	+$19.83M → USCMF
4	$220,507,995	$199,272,029.82	$15,682	$489.96	+$220.49M → USCMF
5	$2,305,125,516	$2,069,181,961.47	$17,547	$547.23	+$2305.11M → USCMF
6	$22,682,014,866	$20,215,530,563.70	$19,632	$611.16	+$22682.00M → USCMF
7	$210,173,620,928	$185,903,865,021.86	$21,963	$682.53	+$210173.60M → USCMF
8	$1,834,794,362,142	$1,609,908,587,748.95	$24,571	$762.18	+$1834794.34M → USCMF
9	$15,098,125,708,837	$13,134,895,741,344.69	$27,486	$851.08	+$15098125.68M → USCMF
10	$117,168,278,921,906	$101,013,284,413,450.45	$30,745	$950.29	+$117168278.89M → USCMF

USCMF vs MRK: Complete Analysis 2026

USCMF — Stock

US Critical Metals Corp. engages in the acquisition, exploration, and development of resource properties. It holds an option to acquire 100% interests in Haynes cobalt project that covers a total area of approximately 192 hectares located in the Blackbird Mining District of the Idaho Cobalt Belt in Idaho; and the Clayton Ridge lithium project, which covers a total area of approximately 712.25 hectares located in Esmeralda County, Nevada. The company is based in Vancouver, Canada.

Full USCMF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this USCMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

USCMF vs SCHD USCMF vs JEPI USCMF vs O USCMF vs KO USCMF vs MAIN USCMF vs JNJ USCMF vs ABBV USCMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.